TY - JOUR
T1 - Which older adults receive sleep medicine specialty care? Predictors of being seen by a board-certified sleep medicine provider
AU - Wickwire, Emerson M.
AU - Jobe, Sophia L.
AU - Parthasarathy, Sairam
AU - Collen, Jacob
AU - Capaldi, Vincent F.
AU - Johnson, Abree
AU - Vadlamani, Aparna
AU - Levri, John M.
AU - Scharf, Steven M.
AU - Albrecht, Jennifer S.
N1 - Funding Information:
This article presents the results from an American Academy of Sleep Medicine Foundation Strategic Research Award, “Demonstrating the Value of Board-Certification in Sleep Medicine,” awarded to the University of Maryland, Baltimore (Principal Investigator: E.M.W.). E.M.W., J.S.A., and S.M.S.’s institution has received research funding from the American Academy of Sleep Medicine Foundation, the Department of Defense, Merck, and ResMed. E.M.W. has served as a scientific consultant to DayZz, Eisai, Merck, and Purdue and is an equity shareholder in WellTap. S.P., J.C., V.F.C., and S.M.S. are board-certified in Sleep Medicine by the American Board of Medical Specialties. S.P. has a patent, UA 14-018 U.S.S.N. 61/884,654; PTAS 502570970 (home breathing device). S.P. reports grant funding from NIH/NHLBI (HL140144, HL-126140, AG059202, HL151254, OD028307, HL138377), grants from Patient Centered Outcomes Research Institute (DI-2018C2-13161, IHS-1306-2505, EAIN no. 3394-UoA, and PPRND-1507-31666), and grants from the American Academy of Sleep Medicine Foundation (169-SR-17) at the time of submission. No other potential conflicts are declared. Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting true views of the Department of the Army or the Department of Defense. All authors have seen and approved the manuscript. This study was not a clinical trial.
Funding Information:
funding from the American Academy of Sleep Medicine Foundation, the Department of Defense, Merck, and ResMed. E.M.W. has served as a scientific consultant to DayZz, Eisai, Merck, and Purdue and is an equity shareholder in WellTap. S.P., J.C., V.F.C., and S.M.S. are board-certified in Sleep Medicine by the American Board of Medical Specialties. S.P. has a patent, UA 14-018 U.S.S.N. 61/884,654; PTAS 502570970 (home breathing device). S.P. reports grant funding from NIH/NHLBI (HL140144, HL-126140, AG059202, HL151254, OD028307, HL138377), grants from Patient Centered Outcomes Research Institute (DI-2018C2-13161, IHS-1306-2505, EAIN no. 3394-UoA, and PPRND-1507-31666), and grants from the American Academy of Sleep Medicine Foundation (169-SR-17) at the time of submission. No other potential conflicts are declared. Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting true views of the Department of the Army or the Department of Defense. All authors have seen and approved the manuscript. This study was not a clinical trial.
Publisher Copyright:
Copyright © 2020 American Academy of Sleep Medicine. All rights reserved.
PY - 2020/11/15
Y1 - 2020/11/15
N2 - Study Objectives: The aim of this study was to characterize older adult Medicare beneficiaries seen by board-certified sleep medicine providers (BCSMPs) and identify predictors of being seen by a BCSMP. Methods: Our data source was a random 5% sample of Medicare administrative claims data (2006–2013). BCSMPs were identified using a cross-matching procedure based on national provider identifiers available within the Medicare database and assigned based on the first sleep disorder diagnosis received. Sleep disorders (insomnia, sleep-related breathing disorders, hypersomnias, circadian rhythm sleep-wake disorders, parasomnias, and restless legs syndrome) were operationalized as International Classification of Disease, Ninth Revision, Clinical Modification diagnostic codes. The number of sleep disorders per beneficiary was computed and compared between BCSMPs and nonspecialists. Logistic regression was used to identify medical and demographic predictors of being seen by a BCSMP. Results: A total of 57,209 beneficiaries received one or more sleep disorder diagnoses during the study period. Of these, 1,279 (2.2%) were initially diagnosed by a BCSMP. Relative to individuals seen by nonspecialists, beneficiaries treated by a BCSMP were more likely to have two or more sleep disorders (9.0% vs 24.1%, P < .001). The most common diagnosis assigned by BCSMPs was obstructive sleep apnea (70.4% of patients seen by BCSMPs were diagnosed with obstructive sleep apnea). The most common diagnosis assigned by nonspecialists was insomnia (48.2% of patients seen by nonspecialists were diagnosed with insomnia). In a fully adjusted regression model, male sex (odds ratio [OR] 1.53; 95% confidence interval [CI] 1.36, 1.72), asthma (OR 1.50; 95% CI 1.30, 1.73), and heart failure (OR 1.24; 95% CI 1.10, 1.41) were positively associated with being treated by a BCSMP. Conversely, depression (OR 0.85, 95% CI 0.73, 1.00), anxiety (OR 0.69, 95% CI .59, .82), Alzheimer and related dementias (OR 0.80, 95% CI .65, .99), and anemia (OR .88, 95% CI .78, .99) were associated with a reduced likelihood of being seen by a BCSMP. Conclusions: Relative to older adults seen by nonspecialists, those seen by BCSMPs are more medically but less psychiatrically complex and are diagnosed with a greater number of sleep disorders. These results suggest the possibility that medically complex patients are referred for specialty care, whereas psychiatrically complex patients might be seen at the nonspecialist level. Further, these results demonstrate the value of board certification in sleep medicine in caring for complex sleep patients.
AB - Study Objectives: The aim of this study was to characterize older adult Medicare beneficiaries seen by board-certified sleep medicine providers (BCSMPs) and identify predictors of being seen by a BCSMP. Methods: Our data source was a random 5% sample of Medicare administrative claims data (2006–2013). BCSMPs were identified using a cross-matching procedure based on national provider identifiers available within the Medicare database and assigned based on the first sleep disorder diagnosis received. Sleep disorders (insomnia, sleep-related breathing disorders, hypersomnias, circadian rhythm sleep-wake disorders, parasomnias, and restless legs syndrome) were operationalized as International Classification of Disease, Ninth Revision, Clinical Modification diagnostic codes. The number of sleep disorders per beneficiary was computed and compared between BCSMPs and nonspecialists. Logistic regression was used to identify medical and demographic predictors of being seen by a BCSMP. Results: A total of 57,209 beneficiaries received one or more sleep disorder diagnoses during the study period. Of these, 1,279 (2.2%) were initially diagnosed by a BCSMP. Relative to individuals seen by nonspecialists, beneficiaries treated by a BCSMP were more likely to have two or more sleep disorders (9.0% vs 24.1%, P < .001). The most common diagnosis assigned by BCSMPs was obstructive sleep apnea (70.4% of patients seen by BCSMPs were diagnosed with obstructive sleep apnea). The most common diagnosis assigned by nonspecialists was insomnia (48.2% of patients seen by nonspecialists were diagnosed with insomnia). In a fully adjusted regression model, male sex (odds ratio [OR] 1.53; 95% confidence interval [CI] 1.36, 1.72), asthma (OR 1.50; 95% CI 1.30, 1.73), and heart failure (OR 1.24; 95% CI 1.10, 1.41) were positively associated with being treated by a BCSMP. Conversely, depression (OR 0.85, 95% CI 0.73, 1.00), anxiety (OR 0.69, 95% CI .59, .82), Alzheimer and related dementias (OR 0.80, 95% CI .65, .99), and anemia (OR .88, 95% CI .78, .99) were associated with a reduced likelihood of being seen by a BCSMP. Conclusions: Relative to older adults seen by nonspecialists, those seen by BCSMPs are more medically but less psychiatrically complex and are diagnosed with a greater number of sleep disorders. These results suggest the possibility that medically complex patients are referred for specialty care, whereas psychiatrically complex patients might be seen at the nonspecialist level. Further, these results demonstrate the value of board certification in sleep medicine in caring for complex sleep patients.
KW - Board certification
KW - Health services
KW - Medicare
KW - Older adults
KW - Sleep
KW - Sleep medicine
UR - http://www.scopus.com/inward/record.url?scp=85096347954&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096347954&partnerID=8YFLogxK
U2 - 10.5664/jcsm.8722
DO - 10.5664/jcsm.8722
M3 - Article
C2 - 32780014
AN - SCOPUS:85096347954
SN - 1550-9389
VL - 16
SP - 1909
EP - 1915
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
IS - 11
ER -